Financial reports
10-Q
2017 Q1
Quarterly report
16 May 17
NT 10-Q
Notice of late quarterly filing
15 May 17
10-K/A
2016 FY
Annual report (amended)
28 Apr 17
10-K
2016 FY
Annual report
17 Mar 17
10-Q
2016 Q3
Quarterly report
9 Nov 16
10-Q
2016 Q2
Quarterly report
11 Aug 16
10-Q
2016 Q3
Quarterly report
7 Jun 16
10-Q
2016 Q2
Quarterly report
22 Mar 16
NT 10-Q
Notice of late quarterly filing
17 Mar 16
10-Q
2016 Q1
Quarterly report
21 Dec 15
Current reports
8-K
Completion of Acquisition or Disposition of Assets
25 Jul 17
8-K
Entry into a Material Definitive Agreement
26 Jun 17
8-K
Entry into a Material Definitive Agreement
22 Jun 17
8-K
Tender and Support Agreement
12 Jun 17
8-K
Miramar Labs, Inc. ® Reports
15 May 17
8-K
Miramar Labs, Inc.® Reports Fourth Quarter and Full Year
17 Mar 17
8-K
Entry into a Material Definitive Agreement
2 Feb 17
8-K
Miramar Labs, Inc. ® Reports Record Third Quarter
8 Nov 16
8-K
Miramar Labs, Inc.® Appoints Patrick F. Williams To Board of Directors
31 Aug 16
8-K
Miramar Labs, Inc. ® Reports Record Second Quarter
11 Aug 16
Registration and prospectus
15-15D
Suspension of duty to report
1 Aug 17
POS AM
Prospectus update (post-effective amendment)
25 Jul 17
SC 14D9/A
Tender offer solicitation (amended)
25 Jul 17
SC TO-T/A
Third party tender offer statement (amended)
25 Jul 17
SC TO-T/A
Third party tender offer statement (amended)
10 Jul 17
SC 14D9
Tender offer solicitation
26 Jun 17
SC TO-C
Information about tender offer
26 Jun 17
SC TO-C
Information about tender offer
26 Jun 17
SC TO-T
Third party tender offer statement
26 Jun 17
SC TO-C
Information about tender offer
14 Jun 17
Proxies
No filings
Other
EFFECT
Notice of effectiveness
27 Jul 17
UPLOAD
Letter from SEC
3 Jul 17
EFFECT
Notice of effectiveness
1 Feb 17
UPLOAD
Letter from SEC
14 Dec 16
CORRESP
Correspondence with SEC
23 Nov 16
UPLOAD
Letter from SEC
10 Nov 16
CT ORDER
Confidential treatment order
15 Sep 16
EFFECT
Notice of effectiveness
21 Feb 14
CORRESP
Correspondence with SEC
19 Feb 14
UPLOAD
Letter from SEC
18 Feb 14